España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Repare Therapeutics
RPTX
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$3.25
-0.0100
-0.31%
At close: -
$3.25
0
0.00%
After Hours: 4:00 PM EDT
Get Report
Comment
Repare Therapeutics (RPTX) Forecast
News
Earnings
Repare Therapeutics (RPTX) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Repare Therapeutics (NASDAQ:RPTX) Stock
Repare Therapeutics Stock (NASDAQ: RPTX)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Tuesday, November 12, 2024
Repare Therapeutics Enters Agreement With US ...
Benzinga Newsdesk
Repare Therapeutics Announces Agreement With ...
Benzinga Newsdesk
Friday, November 08, 2024
HC Wainwright & Co. Reiterates Buy on Repare ...
Benzinga Newsdesk
Thursday, November 07, 2024
Repare Therapeutics Filed To Offer, Sell Comm...
Benzinga Newsdesk
Repare Therapeutics Q3 2024 GAAP EPS $(0.81) ...
Benzinga Newsdesk
Thursday, October 24, 2024
HC Wainwright & Co. Reiterates Buy on Repare ...
Benzinga Newsdesk
Wednesday, October 23, 2024
Repare Therapeutics Presented Updated Data Hi...
Benzinga Newsdesk
Monday, October 14, 2024
Repare Begins Clinical Trial Combining RP-346...
Benzinga Newsdesk
Monday, September 30, 2024
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga Insights
Repare Therapeutics shares are trading higher...
Benzinga Newsdesk
Repare Therapeutics To Present Phase 1 Data H...
Benzinga Newsdesk
Monday, September 23, 2024
HC Wainwright & Co. Reiterates Buy on Repare ...
Benzinga Newsdesk
Friday, September 13, 2024
Repare Therapeutics shares are trading higher...
Benzinga Newsdesk
Repare Therapeutics to Present Phase 1/2 Canc...
Benzinga Newsdesk
Wednesday, September 04, 2024
HC Wainwright & Co. Reiterates Buy on Repare ...
Benzinga Newsdesk
Wednesday, August 28, 2024
Repare Therapeutics Announces Strategic Repri...
Benzinga Newsdesk
Tuesday, August 06, 2024
Repare Therapeutics Q2 EPS $(0.82) Beats $(0....
Benzinga Newsdesk
Theravance Q2 Loss Wider Than Expected, Revenues Rise Y/Y
Zacks
Wednesday, June 26, 2024
Repare Therapeutics Shares Initial Data From ...
Benzinga Newsdesk
Wednesday, June 12, 2024
Foundation Medicine Taps Repare Therapeutics ...
Benzinga Newsdesk
Monday, June 10, 2024
Repare Therapeutics Doses First Patient in Ca...
Benzinga Newsdesk
Wednesday, June 05, 2024
HC Wainwright & Co. Reiterates Buy on Repare ...
Benzinga Newsdesk
Tuesday, June 04, 2024
Repare Therapeutics Receives FDA Fast Track D...
Benzinga Newsdesk
Thursday, May 30, 2024
HC Wainwright & Co. Reiterates Buy on Repare ...
Benzinga Newsdesk
Wednesday, May 29, 2024
Repare Therapeutics' Lunresertib (RP-6306) Ph...
Benzinga Newsdesk
Wednesday, May 08, 2024
Why Upstart Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Avi Kapoor
Repare Therapeutics shares are trading higher...
Benzinga Newsdesk
Why RingCentral Shares Are Trading Higher By 13%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights
Tuesday, May 07, 2024
Repare Therapeutics Q1 EPS $0.30 Beats $0.02 ...
Benzinga Newsdesk
Tuesday, April 30, 2024
Repare Therapeutics And Debiopharm Have Dosed...
Benzinga Newsdesk
Monday, April 15, 2024
Roche's Lymphoma Drug With Chemo Extends Survival In Pretreated Patients
Vandana Singh
Friday, March 08, 2024
HC Wainwright & Co. Reiterates Buy on Repare ...
Benzinga Newsdesk
Wednesday, February 28, 2024
Recap: Repare Therapeutics Q4 Earnings
Benzinga Insights
Wednesday, February 21, 2024
HC Wainwright & Co. Reiterates Buy on Repare ...
Benzinga Newsdesk
Thursday, February 15, 2024
Repare Therapeutics Has Dosed The First Patie...
Benzinga Newsdesk
Wednesday, February 14, 2024
HC Wainwright & Co. Maintains Buy on Repare T...
Benzinga Newsdesk
Tuesday, February 13, 2024
Roche Terminates Cancer Drug Pact With Repare Therapeutics, Its Second Walkout Within A Month
Vandana Singh
Repare Therapeutics shares are trading lower ...
Benzinga Newsdesk
Monday, February 12, 2024
Repare Therapeutics To Regain Global Developm...
Benzinga Newsdesk
Thursday, January 25, 2024
Repare Therapeutics Under Its Worldwide Licen...
Benzinga Newsdesk
Monday, January 08, 2024
Repare Therapeutics Provides Corporate Update...
Benzinga Newsdesk
Thursday, January 04, 2024
Debiopharm Partners With Repare Therapeutics ...
Benzinga Newsdesk
Monday, November 20, 2023
HC Wainwright & Co. Reiterates Buy on Repare ...
Benzinga Newsdesk
Thursday, November 09, 2023
These Biotech Stocks Could Double Your Money, According To Analysts
Aditi Ganguly
Recap: Repare Therapeutics Q3 Earnings
Benzinga Insights
Repare Therapeutics Q3 EPS $(0.45) Beats $(0....
Benzinga Newsdesk
Monday, November 06, 2023
$2.8M Bet On Repare Therapeutics? Check Out These 4 Penny Stocks Insiders Are Aggressively Buying
Lisa Levin
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights
Repare Therapeutics Shares Higher Premarket 1...
Charles Gross
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch